Loading clinical trials...
Loading clinical trials...
Effect of Intravenous Nalbuphine Versus Magnesium Sulfate on Emergence Agitation in Pediatric Patients Scheduled for Hypospadias Repair
Conditions
Interventions
Nalbuphine Versus Magnesium Sulfate
Start Date
April 2, 2024
Primary Completion Date
November 3, 2024
Completion Date
January 30, 2025
Last Updated
March 12, 2024
NCT07427446
NCT07408037
NCT06326983
NCT07046364
NCT06761092
NCT07552259
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions